ライフサイエンスコーパス: intravenous administration

1 per kilogram of maternal weight, in a single intravenous administration).

2 7) at a relatively high level after 2 h upon intravenous administration.

3 o-blood ratio double what was observed after intravenous administration.

4 od that can be achieved safely and simply by intravenous administration.

5 early all conditions, but particularly under intravenous administration.

6 itor for treatment of influenza infection by intravenous administration.

7 transport of plasmid DNA to the brain after intravenous administration.

8 cal barriers that a particle encounters upon intravenous administration.

9 rrier and deliver DNA to the brain following intravenous administration.

10 ity can occur in up to 60% of patients after intravenous administration.

11 at levels roughly ten times lower than after intravenous administration.

12 ungs for treating acute lung injury (ALI) by intravenous administration.

13 trant" drugs were dosed to rats via oral and intravenous administration.

14 ation of individual bacteria in tumors after intravenous administration.

15 transport of plasmid DNA to the brain after intravenous administration.

16 ownregulation in GFP-expressing tumors after intravenous administration.

17 ulting in a failure to reach the brain after intravenous administration.

18 se of their short half-life and the need for intravenous administration.

19 administered (18)F-FDG as an alternative to intravenous administration.

20 r compared with levels typically found after intravenous administration.

21 ntegrins was detected in the lungs 1 h after intravenous administration.

22 ially longer-circulating particles following intravenous administration.

23 assembled into 120 nm particles suitable for intravenous administration.

24 to lactate and alanine within seconds after intravenous administration.

25 re pronounced after intratracheal than after intravenous administration.

26 n with mPEG reduced toxicity associated with intravenous administration.

27 relbine plasma exposure, both after oral and intravenous administration.

28 t 3 time points (30 min, 2 h, and 6 h) after intravenous administration.

29 n tumour tissues versus normal tissues after intravenous administration.

30 icity, especially at early time points after intravenous administration.

31 It can offer several advantages over intravenous administration.

32 nd accumulation in the lungs and liver after intravenous administration.

33 osimetry profile and no adverse events after intravenous administration.

34 peptide showed tumor localization 24 h after intravenous administration.

35 rcentage injected dose [%ID]/g) at 3 h after intravenous administration.

36 and >90 % excretion of QDs within 2 weeks of intravenous administration.

37 ility to specifically reach tumors following intravenous administration.

38 s models and aqueous solubility suitable for intravenous administration.

39 th the observed plasma clearance values upon intravenous administration.

40 After intravenous administration (5 mg/kg), systemic exposure

41 lic substrates in vitro and their subsequent intravenous administration allow both the location of th

42 biexponential pharmacokinetic profile after intravenous administration and a terminal half-life of a

43 ced miR-221 levels in liver within a week of intravenous administration and in situ hybridization stu

44 exhibits desirable kidney distribution after intravenous administration and is fluorescent only after

45 lonal antibodies (mAb) is less invasive than intravenous administration and leads to mAb uptake into

46 Unfavorable liposome biodistribution upon intravenous administration and membrane destabilization

47 high drug concentrations in the blood after intravenous administration and non-specific damages to h

48 nocrystals were determined immediately after intravenous administration and up to 48 h by scintillati

49 17 participants received intravenous administrations and 8 participants received

50 table, with effective doses of 9.5 muSv/MBq (intravenous administration) and 18.1 muSv/MBq (oral admi

51 the dose eliminated within 15 minutes after intravenous administration, and also not significantly a

52 trated a better activity than biphalin after intravenous administration, and its corresponding analog

53 ystemic therapeutic brain delivery following intravenous administration are also reviewed.

54 oxicity compared with systemic toxicity from intravenous administration as previously reported in the

55 ific retention of nanotherapeutics following intravenous administration as seen in the lung, liver, a

56 cts of silica nanoparticles upon single dose intravenous administration at their 10-day maximum toler

57 or to receive placebo (n = 74) by 60-minute intravenous administration before each IMRT fraction.

58 asma concentrations than wild-type mice upon intravenous administration but higher concentrations upo

59 hosphonic acid 4a was observed in rats after intravenous administration, but partial conversion of 4c

60 s observed in solid C4-2B tumours, following intravenous administration, confirming their targeting a

61 hrotoxicity to mice after intraperitoneal or intravenous administration for 1 wk.

62 dependent antinociceptive activity following intravenous administration in a chronic constriction inj

63 growth inhibition following intratumoral or intravenous administration in a mouse tumor model.

64 he IgG-GDNF fusion protein following delayed intravenous administration in acute stroke.

65 tion on paclitaxel biodistribution following intravenous administration in an animal model.

66 nctional delivery of mRNA to the lungs after intravenous administration in mice.

67 gold nanorods (GNRs) in various tissues upon intravenous administration in mice.

68 enetration of the brain parenchyma following intravenous administration in mice.

69 od for determining biodistribution following intravenous administration in murine models.

70 volved in direct nose-to-brain transport) to intravenous administration in terms of effects on region

71 gger anti-apoptotic pathway after repetitive intravenous administrations in mice.

72 oxytocin is quantified after intranasal (not intravenous) administration in brain regions (orbitofron

73 Intravenous administration into LDL receptor null mice o

74 The drug-carrier association after intravenous administration is essential for efficient dr

75 n of radioactivity in different organs after intravenous administration is measured by whole body PET

76 After intravenous administration, lung exposure (area under th

77 However intravenous administration more closely mimics human coc

78 After intravenous administration, NPs of solid PACE (sPACE)-sy

79 After intravenous administration of (125)I-labeled mouse album

80 age IV renal cell cancer was performed after intravenous administration of (15)O-water (10-min dynami

81 2 y) underwent PET/CT imaging after oral and intravenous administration of (18)F-FDG.

82 s (5 men, 4 women) for 190-440 min after the intravenous administration of (18)F-FPEB.

83 ion in the heart was studied over time after intravenous administration of (18)F-LMI1195 in healthy m

84 After intravenous administration of (18)F-RO6958948, (11)C-RO6

85 studies were performed in B6.SJL mice after intravenous administration of (63)Zn-zinc citrate.

86 Upon intravenous administration of (64)Cu-Macrin in rabbits a

87 n 24 h and were imaged as early as 3 h after intravenous administration of (99m)Tc-anti-CD56.

88 f early enhanced T1 mapping (2 minutes after intravenous administration of 0.15 mmol/kg gadobutrol).

89 ography, all mice were scanned 2 hours after intravenous administration of 0.2 mmol/kg body weight of

90 In the adult mouse, intravenous administration of 1 x 10(11) vector genomes

91 Our network meta-analysis demonstrated that intravenous administration of 1,000/200 mg of amoxicilli

92 Intravenous administration of 1.5 mg/kg anti-miR-155 loa

93 In a rhesus monkey model of EVD, once-daily intravenous administration of 10 mg kg(-1) GS-5734 for 1

94 The data also show that the intravenous administration of 10(5) WBCs is sufficient t

95 However, while the intravenous administration of 10(6) CD45(+) or CD4(+)/8(

96 phy of the lower limb (0.625-mm collimation, intravenous administration of 100 mL of iomeprol [400 mg

97 (CT) of the chest, abdomen, and pelvis after intravenous administration of 120 mL of iohexol (Omnipaq

98 Intravenous administration of 2 mg kg(-1) chemically mod

99 everal antiglaucoma drugs and improved after intravenous administration of 20% hyperosmotic glucose s

100 0-min dynamic PET/CT scan of the chest after intravenous administration of 200 MBq of (18)F-fluoromet

101 analyzed ex vivo at 3, 6, 24, and 96 h after intravenous administration of 25 mug of (89)Zr-MSB001085

102 sessed at 6 time points, up to 110 min after intravenous administration of 302 +/- 11 MBq of BAY 8643

103 nt 45-min dynamic PET/CT of the thorax after intravenous administration of 366.3 +/- 14.8 (337.44-394

104 After intravenous administration of 37 MBq (5 mg) of (89)Zr-fr

105 f the breasts and axillary regions 4 d after intravenous administration of 37 MBq of (89)Zr-bevacizum

106 nce of metastatic PCa were studied after the intravenous administration of 370 MBq (10 mCi) of (18)F-

107 of 20 min in duration beginning 80 min after intravenous administration of 370 MBq flortaucipir (18F)

108 (n = 8) underwent PET/CT of the chest after intravenous administration of 370 MBq of (18)F-fluciclov

109 Intravenous administration of 3A in naive rats decreased

110 Intravenous administration of 4F-PCC 50, 25, or 10 IU/kg

111 We compared the effects of intravenous administration of 6% hydroxyethyl starch (ma

112 fed Sprague-Dawley rats, respectively, using intravenous administration of [2-(13) C]-glycine and obs

113 spectroscopic acquisition immediately after intravenous administration of a 0.1 mmol/kg dose of hype

114 Here we show that, after intravenous administration of a collagen-binding domain

115 After intravenous administration of a diuretic, dual-phase CT

116 estigated the immune effects induced by mere intravenous administration of a high dose of sMRBC in mi

117 Ad5 liver transgene expression at 48 h post-intravenous administration of a high viral dose (1x10(1)

118 Intravenous administration of a near-infrared fluorescen

119 ation transfer) images on a 3T scanner after intravenous administration of a pH-responsive contrast a

120 changes in CNS activity within 15 min after intravenous administration of a physiological dose of 4

121 atients underwent cTACE with doxorubicin and intravenous administration of a placebo (cTACE-C) or bev

122 Intravenous administration of a prodrug, chloramphenicol

123 Intravenous administration of a recombinant adenovirus e

124 Patients received a single intravenous administration of a target dose of 0.2-5 x 1

125 ncrease of Kir4.1 expression was obtained by intravenous administration of AAV9-gfaABC1D-Kir4.1-EGFP.

126 Translation of these findings revealed that intravenous administration of alpha2MG-microcapsules (bu

127 muscular dystrophy for 1 year after a single intravenous administration of an adeno-associated virus

128 in which neointima formation was induced by intravenous administration of an adenovirus that encoded

129 We found that intravenous administration of an indole thiazole or a ga

130 Furthermore, systemic intravenous administration of an miR-26a inhibitor, lock

131 a discrete cue (a light) associated with the intravenous administration of an opioid drug (the short-

132 Current treatment involves intravenous administration of anti-inflammatory drugs wh

133 We blocked VWF by intravenous administration of anti-VWF antibodies.

134 ent consisted of removal of all hardware and intravenous administration of antibiotics.

135 f hematopoietic cells via intrabronchial and intravenous administration of antibodies within the same

136 Intravenous administration of AnxA1(2-50) markedly reduc

137 Intravenous administration of atorvastatin during MI lim

138 nsection (to remove sympathetic influences), intravenous administration of atropine increases LV cont

139 Intravenous administration of BB-FCF (1-100 mug kg(-1) )

140 Here we show that intravenous administration of BCG profoundly alters the

141 Early termination of prolonged seizures with intravenous administration of benzodiazepines improves o

142 Intravenous administration of bevacizumab is the standar

143 Intravenous administration of both probes resulted in hi

144 ugated metabolites in plasma and urine after intravenous administration of BPA, BPS, and BPS glucuron

145 Intravenous administration of CAR peptide resulted in in

146 2 W/cm(2), 50% duty cycle, 5 minutes) after intravenous administration of CBLuc with cationic, neutr

147 After intravenous administration of cholate to Oatp1b2-null mi

148 Intravenous administration of cLDL in mice accelerated a

149 Here we report that intravenous administration of CM4620 reduces the severit

150 Intravenous administration of CNH molecules in mice (C57

151 ormal organs and tumor at 48h and 144h after intravenous administration of conjugates.

152 ted contrast-enhanced US was performed after intravenous administration of contrast material before t

153 CT was performed without intravenous administration of contrast material in 155 p

154 nergy CT images acquired 55seconds after the intravenous administration of contrast material in 27 pa

155 T2-weighted sequences, was performed without intravenous administration of contrast material to evalu

156 at 60 seconds (UP) and 5 minutes (EP) after intravenous administration of contrast material.

157 Recently, we have demonstrated that intravenous administration of curcumin limits burn injur

158 Intravenous administration of cyclic Arg-Gly-Asp-d-Phe-C

159 nding expressed as SUVrs were compared after intravenous administration of either 111 MBq (3 mCi) or

160 ntervention (control, CONT) as well as after intravenous administration of either propranolol (PROP),

161 .0 T) 11 d postimplantation before and after intravenous administration of either Robo4- or alpha(V)b

162 with manganese intoxication associated with intravenous administration of ephedrone.

163 Intravenous administration of etelcalcetide (n = 503) or

164 Intravenous administration of EV loaded in LPH-PEG-AA le

165 e were the first to test the hypothesis that intravenous administration of exogenous ghrelin acutely

166 Intravenous administration of exogenous ghrelin increase

167 Intravenous administration of Fab'-CCE conjugate, follow

168 furosemide stress test (FST), which involves intravenous administration of furosemide (1.0 or 1.5 mg/

169 ived from LNPs was detected seven days after intravenous administration of FXN LNPs, suggesting that

170 upt the BBB in rat somatosensory cortex, and intravenous administration of GABA then produced a dose-

171 the upper abdomen acquired 60 seconds after intravenous administration of gadopentetate dimeglumine

172 the upper abdomen acquired 60 seconds after intravenous administration of gadopentetate dimeglumine

173 the upper abdomen acquired 60 seconds after intravenous administration of gadopentetate dimeglumine

174 the upper abdomen acquired 60 seconds after intravenous administration of gadopentetate dimeglumine

175 liver parenchyma before and 20 minutes after intravenous administration of gadoxetic acid).

176 liver parenchyma before and 20 minutes after intravenous administration of gadoxetic acid.

177 ighted (DW) images acquired before and after intravenous administration of Gd-EOB-DTPA.

178 Intravenous administration of GE-137 leads to its accumu

179 Intravenous administration of GLP-1 elicited transient r

180 Intravenous administration of GS-5734 to nonhuman primat

181 Single intravenous administration of h-alpha-Gal A mRNA to Gla-

182 Accordingly, intravenous administration of haptenated syngeneic mouse

183 He was gradually relieved by repeated intravenous administration of high-dose corticosteroid,

184 Intravenous administration of HN3-PE38 alone, or in comb

185 lity barriers is modulated by intrathymic vs intravenous administration of HSCs.

186 mediated plasmonic photothermal therapy, and intravenous administration of HSP targeted HPMA copolyme

187 Intravenous administration of hybrid 13a (H-Dmt-d-Arg-Ab

188 d signals from fumarate and malate following intravenous administration of hyperpolarized fumarate wi

189 Furthermore, intravenous administration of in vivo-jetPEI formulated

190 addition, a second rabbit was studied after intravenous administration of iodinated and tungsten clu

191 ad trauma who had undergone intraarterial or intravenous administration of iodinated contrast materia

192 highest perceived risk of postcontrast AKI, intravenous administration of iodixanol for contrast mat

193 All adverse events related to the intravenous administration of iopamidol during CT examin

194 Intravenous administration of iron isomaltoside, 1000 mg

195 ipants were randomly assigned to a 52-minute intravenous administration of ketamine (0.71 mg/kg, N=17

196 rapamycin (6 mg) or placebo 2 h prior to the intravenous administration of ketamine 0.5 mg/kg in a do

197 ted the efficacy of twice- and thrice-weekly intravenous administration of ketamine in sustaining ini

198 Systemic L-arginine depletion following intravenous administration of l-arginine hydrolyzing enz

199 Given that intravenous administration of L-arginine to human patien

200 In vivo, the intravenous administration of lactoferrin-bearing DAB de

201 Intravenous administration of LDH inhibitors resulted in

202 is of the fusion protein in rabbit following intravenous administration of lipidated TN-ApoA1.

203 Interestingly, intravenous administration of low POVPC doses-which did

204 f contrast material in 155 patients and with intravenous administration of low-osmolality contrast ma

205 Intravenous administration of low-osmolality contrast ma

206 Intravenous administration of M8-B was more effective in

207 LDK procurement, we changed the protocol for intravenous administration of mannitol (i.e., 12.5 or 25

208 Following intravenous administration of model and biodegradable BP

209 If this hypothesis is valid, intravenous administration of MSCs should improve outcom

210 tractive option for cancer gene therapy, the intravenous administration of naked Ad still encounters

211 However, the conventional intravenous administration of nanoparticles for detoxifi

212 Intravenous administration of NEP to wild-type and APP23

213 midbrain, without neurotrophic factors, nor intravenous administration of neurotrophic factors (eith

214 rovide evidence that chronic intrathecal and intravenous administration of NgR1-Fc to cynomolgus monk

215 ute baseline emission scans were followed by intravenous administration of nicotine (1.5 mg/70 kg bod

216 Importantly, intravenous administration of nitrated CCL2 also inhibit

217 Importantly, intravenous administration of o(LA)(8)-PTX-PM is well to

218 Intravenous administration of OPN-305 before reperfusion

219 Once-daily intravenous administration of oritavancin was effective

220 Some mice received an intravenous administration of OX40-activating antibody o

221 stablishes the CHMI-transmission model using intravenous administration of Pf-infected erythrocytes a

222 Thirty minutes after oral or intravenous administration of PhIP (1 mg/kg), the PhIP l

223 Photodynamic therapy (PDT) involves the intravenous administration of photosensitizers followed

224 en patients with NSCLC underwent CT prior to intravenous administration of pimonidazole (0.5 g/m(2)),

225 The intravenous administration of PN2KPI into WT mice dramat

226 Intravenous administration of PN2KPI prolonged the clott

227 Intravenous administration of polyclonal and monoclonal

228 Intravenous administration of prophylactic IL-22 signifi

229 rapies for Gaucher disease include life-long intravenous administration of recombinant glucocerebrosi

230 Intravenous administration of recombinant sialidase incr

231 Intravenous administration of recombinant TRX in wild-ty

232 ncy did not influence bacterial growth after intravenous administration of S. pneumoniae.

233 Intravenous administration of S63845 significantly reduc

234 d, double-blinded, crossover study, with 2-h intravenous administration of saline, GIP, or GLP-1.

235 (11)C-Cimbi717 to 5-HT7R was investigated by intravenous administration of SB-269970 before a second

236 We found that intravenous administration of SC-Exos to type 2 diabetic

237 ematoma, underwent a CE-US examination after intravenous administration of sculpture hexafluoride (do

238 Intravenous administration of sMRBC led to the generatio

239 Systemic intravenous administration of sodium nitrite (8.7 mumol/

240 cell population and toxicity associated with intravenous administration of synthetic RNAs and carrier

241 ic resonance imaging (MRI) and enhance after intravenous administration of the contrast medium.

242 ey radiotracer activity to fall by 50% after intravenous administration of the diuretic (T1/2).

243 he development of an aqueous formulation for intravenous administration of the drug at high dose, imp

244 rowth inhibition was seen after twice-weekly intravenous administration of the drug for three weeks (

245 onal MRI, we determined the acute effects of intravenous administration of the GLP-1 receptor agonist

246 Intravenous administration of the glucuronide resulted i

247 erm mortality between patients who underwent intravenous administration of the iso-osmolar contrast m

248 Finally, intravenous administration of the luciferase reporter Ni

249 Intravenous administration of the MagMBs to mice bearing

250 We previously reported that intravenous administration of the N-methyl-D-aspartate a

251 ol condition in response to noxious heat and intravenous administration of the opioid antagonist nalo

252 ude mice bearing A431 xenograft tumors after intravenous administration of the prepared conjugate wit

253 Up to 48 hours after the intravenous administration of the TNF-alpha antagonist i

254 Here we report that intravenous administration of the Toll-like receptor 7 (

255 Radiation doses after intravenous administration of the tracer in mice and pig

256 were randomly assigned in a 1:1:1:1 ratio to intravenous administration of the triple monoclonal anti

257 Intravenous administration of the XO inhibitor allopurin

258 Significantly, a single-dose intravenous administration of these small neutral NPs lo

259 tection can be achieved through a peripheral intravenous administration of this agent after the initi

260 Our results suggest that intravenous administration of this vaccine will lead to

261 In addition, the intravenous administration of tocotrienol entrapped in t

262 Intravenous administration of tPA increased circulating

263 skeletal muscle of healthy volunteers during intravenous administration of triglycerides plus heparin

264 c or physiologic changes were observed after intravenous administration of up to 1.3 mug of (18)F-FEO

265 e of Blood, Pitchford et al demonstrate that intravenous administration of VEGF-A promotes megakaryoc

266 recting blood-related diseases is the direct intravenous administration of viral vectors, so-called i

267 spite the apparent low infectious titer, the intravenous administration of white blood cells (WBC) re

268 f ziconotide in CSF following intranasal and intravenous administration of ziconotide solution was fo

269 ar: r = 0.173, P = .42.) Conclusion Multiple intravenous administrations of these macrocyclic GBCAs i

270 ithromycin (500 mg via oral, nasogastric, or intravenous administration once daily for 10 days) plus

271 se was significantly higher (20%) than after intravenous administration (P = 0.002).

272 , their long-term toxicity profile following intravenous administration remains unexplored.

273 complement-mediated phagocytosis, and their intravenous administration resulted in high animal morta

274 n and dosimetry for (18)F-FDG after oral and intravenous administrations sequentially in the same sub

275 miR-21i and Dox using HGNPs under NIR after intravenous administration showed high tumor accumulatio

276 rmacokinetic studies of released drugs after intravenous administration showed that the liver-to-plas

277 Following intravenous administration, ss-CyFaP accumulates in neop

278 occur in the body as a result of therapeutic intravenous administration, surgery, infections or decom

279 everal antibiotics with multi-month oral and intravenous administrations that are difficult to implem

280 After intravenous administration, the compound was eliminated

281 of different size has been studied following intravenous administration, the fate of LNCs following p

282 Following intravenous administration, the nanoprobe efficiently ac

283 cally induced and xenograft tumors following intravenous administration, thereby enabling site-specif

284 nanoparticles on their journey from point of intravenous administration to desired destinations such

285 ous SNPs 466.0 +/- 86.0 nm) upon single dose intravenous administration to female and male BALB/c mic

286 well as its excretion profile following its intravenous administration to male Sprague-Dawley rats.

287 Its intravenous administration to mice and Wistar rats gener

288 f (89)Zr-AMG 110 was studied up to 6 d after intravenous administration to nude BALB/c mice bearing h

289 ctor to mediate systemic gene delivery after intravenous administration to perinatal mice and late-ge

290 Following intravenous administration to rodents, 3 exhibits brain

291 xtracellular calcium in vitro or by means of intravenous administration to sensitized mice in vivo be

292 Additionally, following intravenous administration w-MWNTs-ANG showed significan

293 In most cases, the intravenous administration was more effective.

294 Cmax and Tmax of ziconotide in CSF following intravenous administration were found to be 37.78+/-6.8n

295 he most commonly reported symptoms following intravenous administration were malaise or myalgia in th

296 ird day for experimental period after single intravenous administration with ABP/TSTA-SP-exendin-4.

297 Antibodies targeted the murine BBB after intravenous administration with one particular clone, 46

298 epatic metastases than patients who received intravenous administration, with a median intraarterial-

299 Systemic intravenous administration without immunosuppression res

300 ross the blood-brain barrier (BBB) following intravenous administration without noticeable toxicity.